A major symposium is being organized by the European Commission onNovember 4 entitled "The European Union Market Access Strategy - one year on" as a follow-up to the launch of its strategy a year ago, aimed at adjusting EU trade policy to the rapid changes taking place in the world economy and to the needs of European business.
The Commission believes that during the course of last year, its market access initiative started to prove its worth: enquiries and comments were received from thousands of businesses across the EU, and numerous new trade barriers were identified and dealt with by the Commission.
In 1997 alone, the EU will have brought over 40 cases before the World Trade Organization, and any other cases have been dealt with in bilateral negotiations.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze